Monte Rosa Therapeutics (GLUE) PT Raised to $35 at Guggenheim
Tweet Send to a Friend
(Updated - June 30, 2026 7:18 AM EDT)
Guggenheim analyst Michael Schmidt raised the price target on Monte Rosa ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Michael Schmidt raised the price target on Monte Rosa ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
